<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif; font-family: 'Times New Roman', Times, serif;"><div align="LEFT" style="margin-bottom: 0; margin-top: 0;">
<div style="border-bottom: Black 1pt solid; border-top: Black 2pt solid; width: 100%; font-size: 1pt;">&nbsp;</div>
</div>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>SECURITIES AND EXCHANGE COMMISSION</b><br> Washington, D.C. 20549</p>
<p style="margin: 12pt 0 0; text-align: center; font: bold 10pt/normal Times New Roman, Times, Serif;">FORM S-8<br> REGISTRATION STATEMENT UNDER<br> THE SECURITIES ACT OF 1933</p>
<p style="margin: 12pt 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>ADAMIS PHARMACEUTICALS CORPORATION</b><br> (Exact Name of Registrant as Specified in Its Charter)</p>
<table style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse;" cellpadding="0" cellspacing="0">
<tr>
<td style="padding-left: 5.4pt; padding-right: 5.4pt; width: 50%; text-align: center; font-size: 10pt;"><font style="font-size: 10pt;"><b>Delaware</b></font></td>
<td style="padding-left: 5.4pt; padding-right: 5.4pt; width: 50%; text-align: center; font-size: 10pt;"><font style="font-size: 10pt;"><b>82-0429727</b></font></td>
</tr>
<tr>
<td style="padding-left: 5.4pt; padding-right: 5.4pt;">
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;">(State or Other Jurisdiction</p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;">of Incorporation or Organization)</p>
</td>
<td style="padding-left: 5.4pt; padding-right: 5.4pt; text-align: center; font-size: 10pt;"><font style="font-size: 10pt;">(I.R.S. Employer</font><br> <font style="font-size: 10pt;">Identification No.)</font></td>
</tr>
</table>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>&nbsp;</b></p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>11682 El Camino Real, Suite 300</b></p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>San Diego, CA 92130</b></p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;">(Address of Principal Executive Offices)</p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>Adamis Pharmaceuticals Corporation</b></p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>2009 Equity Incentive Plan</b></p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;">(Full Title of the Plan)</p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>&nbsp;</b></p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>Robert O. Hopkins<br> Chief Financial Officer<br> Adamis Pharmaceuticals Corporation</b></p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>11682 El Camino Real, Suite 300</b></p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>San Diego, CA 92130<br> (858) 997-2400</b></p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;">(Name, Address and Telephone Number of Agent For Service)</p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>&nbsp;</b></p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>Copies to:</b><br> C. Kevin Kelso, Esq.<br> Weintraub Tobin Chediak Coleman Grodin Law Corporation<br> 400 Capitol Mall, Suite 1100<br> Sacramento, CA 95814</p>
<p style="margin: 6pt 0; text-align: justify; text-indent: 0in; font: 10pt Times New Roman, Times, Serif;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of &#x201C;accelerated filer and large accelerated filer&#x201D; in Rule&nbsp;12b-2 of the Exchange Act.</p>
<table style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse;" cellpadding="0" cellspacing="0">
<tr>
<td style="padding-left: 6pt; padding-top: 2pt; width: 25%; vertical-align: bottom; text-align: center; text-indent: -6pt; font-size: 10pt;">Large accelerated filer&nbsp;&#x2610;</td>
<td style="width: 19%; vertical-align: bottom; text-align: center; text-indent: 0in; font-size: 10pt;">Accelerated filer&nbsp;&#x2610;</td>
<td style="width: 24%; vertical-align: bottom; text-align: center; text-indent: 0in; font-size: 10pt;">Non-accelerated filer&nbsp;&#x2610;</td>
<td style="width: 32%; vertical-align: top; text-align: center; text-indent: 0in; font-size: 10pt;">Smaller reporting company&nbsp;&#x2612;</td>
</tr>
</table>
<p style="margin: 12pt 0 6pt; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>CALCULATION OF REGISTRATION FEE</b></p>
<table style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse;" cellpadding="0" cellspacing="0">
<tr style="vertical-align: bottom;">
<td style="border-top: Black 1pt solid; padding-left: 5.4pt; padding-right: 5.4pt; width: 36%;">
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>Title of Securities<br> to be Registered</b></p>
<p style="margin: 0; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>&nbsp;</b></p>
</td>
<td style="border-top: Black 1pt solid; padding-left: 5.4pt; padding-right: 5.4pt; width: 15%; text-align: center;"><font style="font-size: 10pt;"><b>Amount</b></font><br> <font style="font-size: 10pt;"><b>to be</b></font><br> <font style="font-size: 10pt;"><b>Registered</b></font><br> <font style="font-size: 10pt;"><b>(2)</b></font></td>
<td style="border-top: Black 1pt solid; padding-left: 5.4pt; padding-right: 5.4pt; width: 17%; text-align: center;"><font style="font-size: 10pt;"><b>Proposed</b></font><br> <font style="font-size: 10pt;"><b>Maximum</b></font><br> <font style="font-size: 10pt;"><b>Offering Price</b></font><br> <font style="font-size: 10pt;"><b>Per Share</b></font></td>
<td style="border-top: Black 1pt solid; padding-left: 5.4pt; padding-right: 5.4pt; width: 17%; text-align: center;"><font style="font-size: 10pt;"><b>Proposed</b></font><br> <font style="font-size: 10pt;"><b>Maximum</b></font><br> <font style="font-size: 10pt;"><b>Aggregate</b></font><br> <font style="font-size: 10pt;"><b>Offering Price</b></font></td>
<td style="border-top: Black 1pt solid; padding-left: 5.4pt; padding-right: 5.4pt; width: 15%; text-align: center;"><font style="font-size: 10pt;"><b>Amount</b></font><br> <font style="font-size: 10pt;"><b>of</b></font><br> <font style="font-size: 10pt;"><b>Registration</b></font><br> <font style="font-size: 10pt;"><b>Fee</b></font></td>
</tr>
<tr style="vertical-align: bottom;">
<td style="border-bottom: Black 1pt solid; padding-left: 5.4pt; padding-right: 5.4pt;">
<p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">Common Stock, $0.0001 par value, to be issued under the 2009 Equity Incentive Plan (<b><i>&#x201C;Plan&#x201D;</i></b>)&nbsp;</p>
</td>
<td style="border-bottom: Black 1pt solid; padding-left: 5.4pt; padding-right: 5.4pt; text-align: center;"><font style="font-size: 10pt;">5,171,583(3)</font></td>
<td style="border-bottom: Black 1pt solid; padding-left: 5.4pt; padding-right: 5.4pt; text-align: center;"><font style="font-size: 10pt;">$8.46 (1)</font></td>
<td style="border-bottom: Black 1pt solid; padding-left: 5.4pt; padding-right: 5.4pt; text-align: center;"><font style="font-size: 10pt;">$43,751,592</font></td>
<td style="border-bottom: Black 1pt solid; padding-left: 5.4pt; padding-right: 5.4pt; text-align: center;"><font style="font-size: 10pt;">$4,405.79</font></td>
</tr>
</table>
<table style="margin-bottom: 0; margin-top: 6pt; font: 10pt Times New Roman, Times, Serif;" cellpadding="0" cellspacing="0" width="100%">
<tr style="vertical-align: top;">
<td style="width: 0;"></td>
<td style="width: 27pt;">(1)</td>
<td style="text-align: justify;">Estimated pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high and low prices per share of the common stock of the Registrant on May 26, 2016, as reported on The NASDAQ Capital Market on May 26, 2016.</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="width: 0;"></td>
<td style="width: 27pt;">(2)</td>
<td style="text-align: justify;">Pursuant to Rule 416(a), this Registration Statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or similar transaction.</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="width: 0;"></td>
<td style="width: 27pt;">(3)</td>
<td style="text-align: justify;">Includes (i) 671,583 shares that were automatically added to the shares authorized for issuance under the Plan pursuant to the Evergreen Provision (defined below) of the 2009 Equity Incentive Plan (the &#x201C;Plan&#x201D;), and (ii) 4,500,000 shares as a result of the approval by the Company and its stockholders to increase the Plan by 4,500,000 shares.</td>
</tr>
</table>
<p style="margin: 0 0 8pt; font: 10pt Times New Roman, Times, Serif;"><b>&nbsp;</b></p>
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt;">
<table style="width: 100%;" cellpadding="0" cellspacing="0">
<tr>
<td style="width: 100%; text-align: center;">&nbsp;</td>
</tr>
</table>
</div><div style="margin-bottom: 6pt; margin-top: 6pt; page-break-before: always;"><table style="width: 100%;" cellpadding="0" cellspacing="0"><tr><td style="width: 100%; text-align: center;">&nbsp;</td></tr></table></div><p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0 0 6pt; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>EXPLANATORY NOTE</b></p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">Pursuant to General Instruction E to Form S-8 under the Securities Act of 1933 (the <b><i>&#x201C;Securities Act&#x201D;</i></b>), this Registration Statement is filed by Adamis Pharmaceuticals Corporation (the <b><i>&#x201C;Registrant&#x201D;</i></b> or the &#x201C;<b><i>Company</i></b>&#x201D;) for the purpose of registering additional shares of Common Stock under the Plan. The basis for this calculation is as follows. The Plan provides that an additional number of shares will automatically be added annually to the 411,765 shares initially authorized for issuance under the Plan on January&nbsp;1, from 2010 until 2019. The number of shares added each year will be equal to (i)&nbsp;five percent (5%) of the total number of shares of Common Stock outstanding on December&nbsp;31st of the preceding calendar year, or (ii)&nbsp;a lesser number of shares of Common Stock determined by the Board of Directors before the start of a calendar year for which an increase applies (the <b><i>&#x201C;Evergreen Provision&#x201D;</i></b>). Accordingly, the number of shares of Common Stock available for issuance under the Plan was increased by 671,583 shares effective January&nbsp;1, 2016. In addition, the Board of Directors and, in May 2016, the stockholders of the Company approved an increase of 4,500,000 shares in the number of shares issuable under the Plan. Accordingly, this Registration Statement registers 5,171,583 additional shares of Common Stock available for issuance under the Plan as a result of such increase and the Evergreen Provisions.</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">The shares of Common Stock registered pursuant to this Registration Statement are of the same class of securities as the (i) 411,765 shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration Statement on Form S-8 (Registration No. 333-159229) originally filed on May&nbsp;13, 2009 (the <b><i>&#x201C;Original Registration Statement&#x201D;</i></b>), (ii) 136,938 shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration Statement on Form S-8 (Registration Number 333-169106) originally filed on August 30, 2010 (the &#x201C;<b><i>Second Registration Statement</i></b>&#x201D;), (iii) 239,972 shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration Statement on Form S-8 (Registration Number 333-175383) originally filed on July 7, 2011 (the &#x201C;<b><i>Third Registration Statement</i></b>&#x201D;), (iv) the 1,073,977 shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration Statement on Form S-8 (Registration Number 333-194635) originally filed on March 17, 2014 (the &#x201C;<b><i>Fourth Registration Statement</i></b>&#x201D;), and (v) the 1,532,597 shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration Statement on Form S-8 (Registration Number 333-201742) originally filed on January 29, 2015 (the &#x201C;<b><i>Fifth Registration Statement</i></b>&#x201D;). The contents of the Original Registration Statement, the Second Registration Statement, the Third Registration Statement, the Fourth Registration Statement, and the Fifth Registation Statement, including any amendments thereto or filings incorporated therein, are incorporated herein by this reference. Any items in the Original Registration Statement, the Second Registration Statement, the Third Registration Statement, the Fourth Registration Statement and the Fifth Registration Statement, not expressly changed hereby shall be as set forth in the Original Registration Statement, the Second Registration Statement, the Third Registration Statement, the Fourth Registration Statement and the Fifth Registration Statement, as applicable.</p>
<p style="background-color: white; margin: 0; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">On December 12, 2013, the Company effected a 1-for-17 reverse stock split of the Company&#x2019;s issued and outstanding Common Stock. In connection with the reverse stock split, the total number of shares then-authorized for issuance under the Plan decreased proportionately to reflect the reverse stock split. The share totals contained in this Registration Statement reflect the 1-for-17 reverse stock split.</p>
<p style="margin: 0 0 8pt; font: 10pt Times New Roman, Times, Serif;"><b>&nbsp;</b></p>
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt;">
<table style="width: 100%;" cellpadding="0" cellspacing="0">
<tr>
<td style="width: 100%; text-align: center; font: normal 10pt Times New Roman, Times, Serif;"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</td>
</tr>
</table>
</div><div style="margin-bottom: 6pt; margin-top: 6pt; page-break-before: always;"><table style="width: 100%;" cellpadding="0" cellspacing="0"><tr><td style="width: 100%; text-align: center;">&nbsp;</td></tr></table></div><p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0 0 6pt; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>PART I</b></p>
<p style="margin: 0 0 6pt; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</b></p>
<table style="margin-bottom: 0; width: 100%; font: 10pt Times New Roman, Times, Serif;" border="0" cellpadding="0" cellspacing="0">
<tr style="vertical-align: top;">
<td style="padding-left: 10pt; width: 10%; text-indent: -10pt;"><b>ITEM 1.</b></td>
<td style="padding-left: 10pt; width: 90%; text-indent: -10pt;"><b>REGISTRANT INFORMATION AND EMPLOYEE PLAN INFORMATION</b></td>
</tr>
</table>
<p style="margin: 0; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0 0 6pt; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">Not required to be filed with this Registration Statement.</p>
<table style="margin-bottom: 0; width: 100%; font: 10pt Times New Roman, Times, Serif;" border="0" cellpadding="0" cellspacing="0">
<tr style="vertical-align: top;">
<td style="padding-left: 10pt; width: 10%; text-indent: -10pt;"><b>ITEM 2.</b></td>
<td style="padding-left: 10pt; width: 90%; text-indent: -10pt;"><b>REGISTRANT INFORMATION AND EMPLOYEE PLAN INFORMATION</b></td>
</tr>
</table>
<p style="margin: 0; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0 0 6pt; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">Not required to be filed with this Registration Statement.</p>
<p style="margin: 0 0 6pt; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>PART II</b></p>
<p style="margin: 0 0 6pt; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</b></p>
<table style="margin-bottom: 0; width: 100%; font: 10pt Times New Roman, Times, Serif;" border="0" cellpadding="0" cellspacing="0">
<tr style="vertical-align: top;">
<td style="padding-left: 10pt; width: 10%; text-indent: -10pt;"><b>ITEM 3.</b></td>
<td style="padding-left: 10pt; width: 90%; text-indent: -10pt;"><b>INFORMATION INCORPORATED BY REFERENCE.</b></td>
</tr>
</table>
<p style="margin: 0; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">The Registrant hereby incorporates by reference into this Registration Statement the following documents and information previously filed with the Securities and Exchange Commission (<b><i>&#x201C;Commission&#x201D;</i></b>):</p>
<table style="margin-bottom: 0; margin-top: 0; width: 100%; font: 10pt Times New Roman, Times, Serif;" cellpadding="0" cellspacing="0">
<tr style="vertical-align: top;">
<td style="width: 0.5in;"></td>
<td style="width: 0.5in;">(a)</td>
<td style="text-align: justify;">The Registrant&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2015.</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td></td>
<td>(b)</td>
<td style="text-align: justify;">All other reports filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the <b><i>&#x201C;Exchange Act&#x201D;</i></b>), since the end of the fiscal year covered by the annual report referred to in (a) above.</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td></td>
<td>(c)</td>
<td style="text-align: justify;">The description of the Registrant&#x2019;s Common Stock contained in the Registrant&#x2019;s registration statement on Form 8-A (Reg. No. 000-26372) filed with the Commission on September&nbsp;7, 2004 and registration statement on Form 8-A (Reg. No. 001-36242) filed with the Commission on December 11, 2013 under Section 12 of the Exchange Act, including any amendment or report filed for the purpose of updating such description.</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td></td>
<td>(d)</td>
<td style="text-align: justify;">All documents that we subsequently file under Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act before we file a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents, except as to specific sections of such statements as set forth therein. Unless expressly incorporated into this Registration Statement, a report furnished on Form 8-K prior or subsequent to the date hereof, shall not be incorporated by reference into this Registration Statement.</td>
</tr>
</table>
<p style="margin: 0; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">Any statement incorporated herein shall be deemed to be modified or superseded for the purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document that is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.</p>
<table style="margin-bottom: 0; width: 100%; font: 10pt Times New Roman, Times, Serif;" border="0" cellpadding="0" cellspacing="0">
<tr style="vertical-align: top;">
<td style="padding-left: 10pt; width: 10%; text-indent: -10pt;"><b>ITEM 4.</b></td>
<td style="padding-left: 10pt; width: 90%; text-indent: -10pt;"><b>DESCRIPTION OF SECURITIES.</b></td>
</tr>
</table>
<p style="margin: 0; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0 0 6pt; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">Not applicable.</p>
<table style="margin-bottom: 0; width: 100%; font: 10pt Times New Roman, Times, Serif;" border="0" cellpadding="0" cellspacing="0">
<tr style="vertical-align: top;">
<td style="padding-left: 10pt; width: 10%; text-indent: -10pt;"><b>ITEM 5.</b></td>
<td style="padding-left: 10pt; width: 90%; text-indent: -10pt;"><b>INTERESTS OF NAMED EXPERTS AND COUNSEL.</b></td>
</tr>
</table>
<p style="margin: 0; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0 0 6pt; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">Not applicable.<b>&nbsp;</b></p>
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt;">
<table style="width: 100%;" cellpadding="0" cellspacing="0">
<tr>
<td style="width: 100%; text-align: center; font: normal 10pt Times New Roman, Times, Serif;"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</td>
</tr>
</table>
</div><div style="margin-bottom: 6pt; margin-top: 6pt; page-break-before: always;"><table style="width: 100%;" cellpadding="0" cellspacing="0"><tr><td style="width: 100%; text-align: center;">&nbsp;</td></tr></table></div><p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<table style="margin-bottom: 0; width: 100%; font: 10pt Times New Roman, Times, Serif;" border="0" cellpadding="0" cellspacing="0">
<tr style="vertical-align: top;">
<td style="padding-left: 10pt; width: 10%; text-indent: -10pt;"><b>ITEM 6.</b></td>
<td style="padding-left: 10pt; width: 90%; text-indent: -10pt;"><b>INDEMNIFICATION OF DIRECTORS AND OFFICERS.</b></td>
</tr>
</table>
<p style="margin: 0; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">The Registrant is incorporated under the laws of the State of Delaware. Section&nbsp;145 of the Delaware General Corporation Law provides that a Delaware corporation may&nbsp;indemnify any persons who are, or are threatened to be made, parties to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person was an officer, director, employee or agent of such corporation, or is or was serving at the request of such person as an officer, director, employee or agent of another corporation or enterprise. The indemnity may&nbsp;include expenses (including attorneys&#x2019; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation&#x2019;s best interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was illegal. Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him or her against the expenses, which such officer or director has actually and reasonably incurred. The Registrant&#x2019;s amended and restated certificate of incorporation and amended and restated bylaws provide for the indemnification of its directors and officers to the fullest extent permitted under the Delaware General Corporation Law.</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">Registrant has entered into Indemnity Agreements with its current directors to give such directors additional contractual assurances regarding the scope of the indemnification set forth in the amended and restated certificate of incorporation and to provide additional procedural protections.</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">See also the undertakings set out in response to Item&nbsp;9.</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">The indemnification provisions in the Registrant&#x2019;s Bylaws and the Indemnity Agreements described above may be sufficiently broad to indemnify such individuals, under certain circumstances, for liabilities (including reimbursement of expenses incurred) arising under the Securities Act.</p>
<table style="margin-bottom: 0; width: 100%; font: 10pt Times New Roman, Times, Serif;" border="0" cellpadding="0" cellspacing="0">
<tr style="vertical-align: top;">
<td style="padding-left: 10pt; width: 10%; text-indent: -10pt;"><b>ITEM 7.</b></td>
<td style="padding-left: 10pt; width: 90%; text-indent: -10pt;"><b>EXEMPTION FROM REGISTRATION CLAIMED.</b></td>
</tr>
</table>
<p style="margin: 0; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">Not applicable.</p>
<table style="margin-bottom: 0; width: 100%; font: 10pt Times New Roman, Times, Serif;" border="0" cellpadding="0" cellspacing="0">
<tr style="vertical-align: top;">
<td style="padding-left: 10pt; width: 10%; text-indent: -10pt;"><b>ITEM 8.</b></td>
<td style="padding-left: 10pt; width: 90%; text-indent: -10pt;"><b>EXHIBITS.</b></td>
</tr>
</table>
<p style="margin: 0; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">The following documents are filed as exhibits to this Registration Statement:</p>
<table style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse;" cellpadding="0" cellspacing="0">
<tr style="vertical-align: top;">
<td style="padding-right: 4.5pt; width: 10%; text-decoration: underline;"><font style="font-size: 10pt;"><u>Exhibit No</u>.</font></td>
<td style="padding-right: 4.5pt; width: 2%;">&nbsp;</td>
<td style="padding-right: 4.5pt; width: 88%; text-decoration: underline;"><font style="font-size: 10pt;"><u>Description</u></font></td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;"><font style="font-size: 10pt;">4.01</font></td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;"><font style="font-size: 10pt;">Restated Certificate of Incorporation (Incorporated by reference to exhibits filed with the Company&#x2019;s registration statement on Form S-8, file no. 333-194635, filed on March 17, 2014.). </font></td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;"><font style="font-size: 10pt;">4.02</font></td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;"><font style="font-size: 10pt;">Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock.&nbsp;&nbsp;(Incorporated by reference to exhibits filed with the Report on Form 8-K, filed on August 20, 2014.)</font></td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">4.03<font style="font-size: 10pt;">&nbsp;</font></td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;"><font style="font-size: 10pt;">Certificate of Designation of Preferences, Rights and Limitations of Series A-1 Convertible Preferred Stock.&nbsp;&nbsp;(Incorporated by reference to exhibits filed with the Report on Form 8-K, filed on January 26, 2016).</font></td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">4.04</td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">Amended and Restated Bylaws of the Company (incorporated herein by reference to exhibits previously filed on Form&nbsp;S-4/A filed January&nbsp;12, 2009, file no. 333-155322).</td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;"><font style="font-size: 10pt;">4.05</font></td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;"><font style="font-size: 10pt;">Adamis Pharmaceuticals Corporation 2009 Equity Incentive Plan (incorporated herein by reference to exhibits filed with the Company&#x2019;s Quarterly Report on Form 10-Q, filed November 14, 2014). </font></td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;"><font style="font-size: 10pt;">4.06</font></td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;"><font style="font-size: 10pt;">Form of Option Agreements under 2009 Equity Incentive Plan (incorporated by reference to exhibits filed with the Form 8-K, filed on September 16, 2011.</font></td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;"><font style="font-size: 10pt;">4.07</font></td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;"><font style="font-size: 10pt;">Form of Restricted Stock Unit Award Grant Notice and Award Agreement under 2009 Equity Incentive Plan. (incorporated by reference to exhibits filed with the Registration Statement on Form S-8, file no. 333-194635, filed March 17, 2014).&nbsp;&nbsp;</font></td>
</tr>
</table>
<p style="margin: 0 0 8pt; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt;">
<table style="width: 100%;" cellpadding="0" cellspacing="0">
<tr>
<td style="width: 100%; text-align: center; font: normal 10pt Times New Roman, Times, Serif;"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</td>
</tr>
</table>
</div><div style="margin-bottom: 6pt; margin-top: 6pt; page-break-before: always;"><table style="width: 100%;" cellpadding="0" cellspacing="0"><tr><td style="width: 100%; text-align: center;">&nbsp;</td></tr></table></div><p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<table style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse;" cellpadding="0" cellspacing="0">
<tr style="vertical-align: top;">
<td style="width: 10%; text-align: justify;"><font style="font-size: 10pt;">4.08</font></td>
<td style="width: 2%; text-align: justify;">&nbsp;</td>
<td style="width: 88%; text-align: justify;"><font style="font-size: 10pt;">Form of Restricted Stock Unit Award Grant Notice and Award Agreement for Non-Employee Directors under 2009 Equity Incentive Plan. (incorporated by reference to exhibits filed with the Registration Statement on Form S-8, file no. 333-194635, filed March 17, 2014).&nbsp;&nbsp;</font></td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;"><font style="font-size: 10pt;">4.09</font></td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;"><font style="font-size: 10pt;">Form of Option Agreement for Non-Employee Directors (incorporated by reference to exhibits filed with the Report on Form 8-K, filed January 13, 2011).</font></td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;"><font style="font-size: 10pt;">5.01</font></td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;"><font style="font-size: 10pt;"><a href="ex5-01.htm">Opinion of Weintraub Tobin Chediak Coleman Grodin Law Corporation.</a></font></td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;"><font style="font-size: 10pt;">23.01</font></td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;"><font style="font-size: 10pt;"><a href="ex23-01.htm">Consent of Mayer Hoffman McCann P.C., Independent Registered Public Accounting Firm.</a></font></td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">
<p style="margin-bottom: 0; margin-top: 0;"><font style="font-size: 10pt;">23.02</font></p>
</td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;"><font style="font-size: 10pt;">Consent of Weintraub Tobin Chediak Coleman Grodin Law Corporation (included in Exhibit 5.01).</font></td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="text-align: justify;"><font style="font-size: 10pt;">24.01</font></td>
<td style="text-align: justify;">&nbsp;</td>
<td style="text-align: justify;"><font style="font-size: 10pt;">Power of Attorney (see signature page).</font></td>
</tr>
</table>
<p style="margin: 0; font: 10pt Times New Roman, Times, Serif;"><b>&nbsp;</b></p>
<table style="margin-bottom: 0; width: 100%; font: 10pt Times New Roman, Times, Serif;" border="0" cellpadding="0" cellspacing="0">
<tr style="vertical-align: top;">
<td style="padding-left: 10pt; width: 10%; text-indent: -10pt;"><b>ITEM 9.</b></td>
<td style="padding-left: 10pt; width: 90%; text-indent: -10pt;"><b>UNDERTAKINGS.</b></td>
</tr>
</table>
<p style="margin: 0; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">The undersigned Registrant hereby undertakes:</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: (i) to include any prospectus required by Section 10(a)(3) of the Securities Act; (ii) to reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information in the Registration Statement; and (iii) to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement; provided, however, that (i) and (ii) do not apply if the information required to be included in a post-effective amendment thereby is contained in periodic reports filed by the Registrant pursuant to Section&nbsp;13 or Section 15(d) of the Exchange Act that are incorporated by reference into the Registration Statement.</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">(4) That, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#x2019;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act that is incorporated by reference in this Registration Statement shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the provisions described under Item 6 above, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</p>
<p style="margin: 0 0 8pt; font: 10pt Times New Roman, Times, Serif;"><b>&nbsp;</b></p>
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt;">
<table style="width: 100%;" cellpadding="0" cellspacing="0">
<tr>
<td style="width: 100%; text-align: center; font: normal 10pt Times New Roman, Times, Serif;"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</td>
</tr>
</table>
</div><div style="margin-bottom: 6pt; margin-top: 6pt; page-break-before: always;"><table style="width: 100%;" cellpadding="0" cellspacing="0"><tr><td style="width: 100%; text-align: center;">&nbsp;</td></tr></table></div><p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<p style="margin: 0 0 6pt; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>SIGNATURES</b></p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, California, on this 1st day of June, 2016.</p>
<table style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse;" cellpadding="0" cellspacing="0">
<tr style="vertical-align: top;">
<td style="text-align: justify;">&nbsp;</td>
<td colspan="2"><font style="font-size: 10pt;"><b>ADAMIS PHARMACEUTICALS CORPORATION</b></font></td>
</tr>
<tr style="vertical-align: top;">
<td style="width: 60%;">&nbsp;</td>
<td style="width: 5%;">&nbsp;</td>
<td style="width: 35%;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td><font style="font-size: 10pt;">By:</font></td>
<td style="border-bottom: Black 1pt solid;"><font style="font-size: 10pt;">/s/ Robert O. Hopkins</font></td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td><font style="font-size: 10pt;">Robert O. Hopkins</font></td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td><font style="font-size: 10pt;">Chief Financial Officer</font></td>
</tr>
</table>
<p style="margin: 0 0 8pt; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>

<p style="margin: 0 0 8pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</p>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></div>
    <div style="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></div>
    <!-- Field: /Page -->

<p style="margin: 0 0 8pt; font: 10pt Times New Roman, Times, Serif"></p>

<p style="margin: 0 0 6pt; text-align: center; font: 10pt Times New Roman, Times, Serif;"><b>POWER OF ATTORNEY</b></p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">KNOW ALL BY THESE PRESENTS that each individual whose signature appears below constitutes and appoints Dennis J. Carlo and Robert O. Hopkins, and each of them, his attorneys-in-fact, and agents, each with the power of substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney may be signed in one or more counterparts.</p>
<p style="margin: 0 0 6pt; text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif;">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.</p>
<p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>
<table style="width: 100%; font: 10pt Times New Roman, Times, Serif;" cellpadding="0" cellspacing="0">
<tr style="vertical-align: bottom;">
<td style="border-bottom: black 1.5pt solid; width: 37%; text-align: center;"><font style="font-size: 10pt;"><b>Name</b></font></td>
<td style="width: 2%;">&nbsp;</td>
<td style="border-bottom: black 1.5pt solid; width: 46%; text-align: center;"><font style="font-size: 10pt;"><b>Title</b></font></td>
<td style="border-bottom: black 1.5pt solid; width: 15%; text-align: center;"><font style="font-size: 10pt;"><b>Date</b></font></td>
</tr>
<tr style="vertical-align: top;">
<td><font style="font-size: 10pt;"><b>Principal Executive Officer:</b></font></td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="border-bottom: Black 1pt solid;">
<p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">/s/ Dennis J. Carlo</p>
</td>
<td>&nbsp;</td>
<td><font style="font-size: 10pt;">Chief Executive Officer and Director</font></td>
<td><font style="font-size: 10pt;">June 1, 2016</font></td>
</tr>
<tr style="vertical-align: top;">
<td>Dennis J. Carlo, Ph.D.</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: right;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td><font style="font-size: 10pt;"><b>Principal Financial Officer</b></font></td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td><font style="font-size: 10pt;"><b>and Principal Accounting Officer:</b></font></td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td><font style="font-size: 10pt;"><b>&nbsp;&nbsp;</b></font></td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: right;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: right;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="border-bottom: Black 1pt solid; padding-bottom: 0;">
<p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">/s/ Robert O. Hopkins</p>
</td>
<td>&nbsp;</td>
<td>
<p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">Vice President, Finance, Chief Financial Officer</p>
</td>
<td style="padding-left: 0.05pt; padding-right: -31.55pt;"><font style="font-size: 10pt;">June 1, 2016</font></td>
</tr>
<tr style="vertical-align: top;">
<td>Robert O. Hopkins</td>
<td>&nbsp;</td>
<td>and Secretary</td>
<td style="text-align: right;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td><font style="font-size: 10pt;"><b>Directors:</b></font></td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: right;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: right;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="border-bottom: Black 1pt solid;">
<p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">/s/ David J. Marguglio</p>
</td>
<td>&nbsp;</td>
<td><font style="font-size: 10pt;">Director</font></td>
<td><font style="font-size: 10pt;">June 1, 2016</font></td>
</tr>
<tr style="vertical-align: top;">
<td>David J. Marguglio</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: right;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: right;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="border-bottom: Black 1pt solid;">
<p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">/s/ William C. Denby, III</p>
</td>
<td>&nbsp;</td>
<td><font style="font-size: 10pt;">Director</font></td>
<td><font style="font-size: 10pt;">June 1, 2016</font></td>
</tr>
<tr style="vertical-align: top;">
<td>William C. Denby, III</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: right;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: right;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="border-bottom: Black 1pt solid;">
<p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">/s/ Robert B. Rothermel</p>
</td>
<td>&nbsp;</td>
<td><font style="font-size: 10pt;">Director</font></td>
<td><font style="font-size: 10pt;">June 1, 2016</font></td>
</tr>
<tr style="vertical-align: top;">
<td>Robert B. Rothermel</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: right;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td style="text-align: right;">&nbsp;</td>
</tr>
<tr style="vertical-align: top;">
<td style="border-bottom: Black 1pt solid;">
<p style="margin: 0; font: 10pt Times New Roman, Times, Serif;">/s/ Richard C. Williams</p>
</td>
<td>&nbsp;</td>
<td><font style="font-size: 10pt;">Director</font></td>
<td><font style="font-size: 10pt;">June 1, 2016</font></td>
</tr>
<tr style="vertical-align: top;">
<td>Richard C. Williams</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
</table>
<p style="margin: 0 0 6pt; text-align: justify; font: 10pt Times New Roman, Times, Serif;">&nbsp;</p>

<p style="margin: 0 0 6pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"></p>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></div>
    <!-- Field: /Page -->

<p style="margin: 0 0 6pt; text-align: justify; font: 10pt Times New Roman, Times, Serif"><b>&nbsp;</b></p>
</body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "admp-s8_0516.htm", "description": "INITIAL REGISTRATION STATEMENT", "secsgml_size_bytes": 52263}]
{"company-data": {"conformed-name": "Adamis Pharmaceuticals Corp", "cik": "0000887247", "assigned-sic": "2834", "irs-number": "820429727", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-211773", "film-number": "161690606"}, "business-address": {"street1": "11455 EL CAMINO REAL", "street2": "SUITE 310", "city": "SAN DIEGO", "state": "CA", "zip": "92130", "phone": "(858) 997-2400"}, "mail-address": {"street1": "11455 EL CAMINO REAL", "street2": "SUITE 310", "city": "SAN DIEGO", "state": "CA", "zip": "92130"}, "former-company": {"former-conformed-name": "CELLEGY PHARMACEUTICALS INC", "date-changed": "19950615"}}
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
ADAMIS PHARMACEUTICALS CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
Delaware
82-0429727
(State or Other Jurisdiction
of Incorporation or Organization)
(I.R.S. Employer
Identification No.)
11682 El Camino Real, Suite 300
San Diego, CA 92130
(Address of Principal Executive Offices)
Adamis Pharmaceuticals Corporation
2009 Equity Incentive Plan
(Full Title of the Plan)
Robert O. Hopkins
Chief Financial Officer
Adamis Pharmaceuticals Corporation
11682 El Camino Real, Suite 300
San Diego, CA 92130
(858) 997-2400
(Name, Address and Telephone Number of Agent For Service)
Copies to:
C. Kevin Kelso, Esq.
Weintraub Tobin Chediak Coleman Grodin Law Corporation
400 Capitol Mall, Suite 1100
Sacramento, CA 95814
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐
Accelerated filer ☐
Non-accelerated filer ☐
Smaller reporting company ☒
CALCULATION OF REGISTRATION FEE
Title of Securities
to be Registered
Amount
to be
Registered
(2)
Proposed
Maximum
Offering Price
Per Share
Proposed
Maximum
Aggregate
Offering Price
Amount
of
Registration
Fee
Common Stock, $0.0001 par value, to be issued under the 2009 Equity Incentive Plan (
"Plan"
)
5,171,583(3)
$8.46 (1)
$43,751,592
$4,405.79
(1)
Estimated pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high and low prices per share of the common stock of the Registrant on May 26, 2016, as reported on The NASDAQ Capital Market on May 26, 2016.
(2)
Pursuant to Rule 416(a), this Registration Statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or similar transaction.
(3)
Includes (i) 671,583 shares that were automatically added to the shares authorized for issuance under the Plan pursuant to the Evergreen Provision (defined below) of the 2009 Equity Incentive Plan (the "Plan"), and (ii) 4,500,000 shares as a result of the approval by the Company and its stockholders to increase the Plan by 4,500,000 shares.
EXPLANATORY NOTE
Pursuant to General Instruction E to Form S-8 under the Securities Act of 1933 (the
"Securities Act"
), this Registration Statement is filed by Adamis Pharmaceuticals Corporation (the
"Registrant"
or the "
Company
") for the purpose of registering additional shares of Common Stock under the Plan. The basis for this calculation is as follows. The Plan provides that an additional number of shares will automatically be added annually to the 411,765 shares initially authorized for issuance under the Plan on January 1, from 2010 until 2019. The number of shares added each year will be equal to (i) five percent (5%) of the total number of shares of Common Stock outstanding on December 31st of the preceding calendar year, or (ii) a lesser number of shares of Common Stock determined by the Board of Directors before the start of a calendar year for which an increase applies (the
"Evergreen Provision"
). Accordingly, the number of shares of Common Stock available for issuance under the Plan was increased by 671,583 shares effective January 1, 2016. In addition, the Board of Directors and, in May 2016, the stockholders of the Company approved an increase of 4,500,000 shares in the number of shares issuable under the Plan. Accordingly, this Registration Statement registers 5,171,583 additional shares of Common Stock available for issuance under the Plan as a result of such increase and the Evergreen Provisions.
The shares of Common Stock registered pursuant to this Registration Statement are of the same class of securities as the (i) 411,765 shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration Statement on Form S-8 (Registration No. 333-159229) originally filed on May 13, 2009 (the
"Original Registration Statement"
), (ii) 136,938 shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration Statement on Form S-8 (Registration Number 333-169106) originally filed on August 30, 2010 (the "
Second Registration Statement
"), (iii) 239,972 shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration Statement on Form S-8 (Registration Number 333-175383) originally filed on July 7, 2011 (the "
Third Registration Statement
"), (iv) the 1,073,977 shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration Statement on Form S-8 (Registration Number 333-194635) originally filed on March 17, 2014 (the "
Fourth Registration Statement
"), and (v) the 1,532,597 shares of Common Stock registered for issuance under the Plan pursuant to the currently effective Registration Statement on Form S-8 (Registration Number 333-201742) originally filed on January 29, 2015 (the "
Fifth Registration Statement
"). The contents of the Original Registration Statement, the Second Registration Statement, the Third Registration Statement, the Fourth Registration Statement, and the Fifth Registation Statement, including any amendments thereto or filings incorporated therein, are incorporated herein by this reference. Any items in the Original Registration Statement, the Second Registration Statement, the Third Registration Statement, the Fourth Registration Statement and the Fifth Registration Statement, not expressly changed hereby shall be as set forth in the Original Registration Statement, the Second Registration Statement, the Third Registration Statement, the Fourth Registration Statement and the Fifth Registration Statement, as applicable.
On December 12, 2013, the Company effected a 1-for-17 reverse stock split of the Company's issued and outstanding Common Stock. In connection with the reverse stock split, the total number of shares then-authorized for issuance under the Plan decreased proportionately to reflect the reverse stock split. The share totals contained in this Registration Statement reflect the 1-for-17 reverse stock split.
1
PART I
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 1.
REGISTRANT INFORMATION AND EMPLOYEE PLAN INFORMATION
Not required to be filed with this Registration Statement.
ITEM 2.
REGISTRANT INFORMATION AND EMPLOYEE PLAN INFORMATION
Not required to be filed with this Registration Statement.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3.
INFORMATION INCORPORATED BY REFERENCE.
The Registrant hereby incorporates by reference into this Registration Statement the following documents and information previously filed with the Securities and Exchange Commission (
"Commission"
):
(a)
The Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2015.
(b)
All other reports filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"
), since the end of the fiscal year covered by the annual report referred to in (a) above.
(c)
The description of the Registrant's Common Stock contained in the Registrant's registration statement on Form 8-A (Reg. No. 000-26372) filed with the Commission on September 7, 2004 and registration statement on Form 8-A (Reg. No. 001-36242) filed with the Commission on December 11, 2013 under Section 12 of the Exchange Act, including any amendment or report filed for the purpose of updating such description.
(d)
All documents that we subsequently file under Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act before we file a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents, except as to specific sections of such statements as set forth therein. Unless expressly incorporated into this Registration Statement, a report furnished on Form 8-K prior or subsequent to the date hereof, shall not be incorporated by reference into this Registration Statement.
Any statement incorporated herein shall be deemed to be modified or superseded for the purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document that is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
ITEM 4.
DESCRIPTION OF SECURITIES.
Not applicable.
ITEM 5.
INTERESTS OF NAMED EXPERTS AND COUNSEL.
Not applicable.
2
ITEM 6.
INDEMNIFICATION OF DIRECTORS AND OFFICERS.
The Registrant is incorporated under the laws of the State of Delaware. Section 145 of the Delaware General Corporation Law provides that a Delaware corporation may indemnify any persons who are, or are threatened to be made, parties to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person was an officer, director, employee or agent of such corporation, or is or was serving at the request of such person as an officer, director, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation's best interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was illegal. Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him or her against the expenses, which such officer or director has actually and reasonably incurred. The Registrant's amended and restated certificate of incorporation and amended and restated bylaws provide for the indemnification of its directors and officers to the fullest extent permitted under the Delaware General Corporation Law.
Registrant has entered into Indemnity Agreements with its current directors to give such directors additional contractual assurances regarding the scope of the indemnification set forth in the amended and restated certificate of incorporation and to provide additional procedural protections.
See also the undertakings set out in response to Item 9.
The indemnification provisions in the Registrant's Bylaws and the Indemnity Agreements described above may be sufficiently broad to indemnify such individuals, under certain circumstances, for liabilities (including reimbursement of expenses incurred) arising under the Securities Act.
ITEM 7.
EXEMPTION FROM REGISTRATION CLAIMED.
Not applicable.
ITEM 8.
EXHIBITS.
The following documents are filed as exhibits to this Registration Statement:
Exhibit No
.
Description
4.01
Restated Certificate of Incorporation (Incorporated by reference to exhibits filed with the Company's registration statement on Form S-8, file no. 333-194635, filed on March 17, 2014.).
4.02
Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock.  (Incorporated by reference to exhibits filed with the Report on Form 8-K, filed on August 20, 2014.)
4.03
Certificate of Designation of Preferences, Rights and Limitations of Series A-1 Convertible Preferred Stock.  (Incorporated by reference to exhibits filed with the Report on Form 8-K, filed on January 26, 2016).
4.04
Amended and Restated Bylaws of the Company (incorporated herein by reference to exhibits previously filed on Form S-4/A filed January 12, 2009, file no. 333-155322).
4.05
Adamis Pharmaceuticals Corporation 2009 Equity Incentive Plan (incorporated herein by reference to exhibits filed with the Company's Quarterly Report on Form 10-Q, filed November 14, 2014).
4.06
Form of Option Agreements under 2009 Equity Incentive Plan (incorporated by reference to exhibits filed with the Form 8-K, filed on September 16, 2011.
4.07
Form of Restricted Stock Unit Award Grant Notice and Award Agreement under 2009 Equity Incentive Plan. (incorporated by reference to exhibits filed with the Registration Statement on Form S-8, file no. 333-194635, filed March 17, 2014).
3
4.08
Form of Restricted Stock Unit Award Grant Notice and Award Agreement for Non-Employee Directors under 2009 Equity Incentive Plan. (incorporated by reference to exhibits filed with the Registration Statement on Form S-8, file no. 333-194635, filed March 17, 2014).
4.09
Form of Option Agreement for Non-Employee Directors (incorporated by reference to exhibits filed with the Report on Form 8-K, filed January 13, 2011).
5.01
Opinion of Weintraub Tobin Chediak Coleman Grodin Law Corporation.
23.01
Consent of Mayer Hoffman McCann P.C., Independent Registered Public Accounting Firm.
23.02
Consent of Weintraub Tobin Chediak Coleman Grodin Law Corporation (included in Exhibit 5.01).
24.01
Power of Attorney (see signature page).
ITEM 9.
UNDERTAKINGS.
The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: (i) to include any prospectus required by Section 10(a)(3) of the Securities Act; (ii) to reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information in the Registration Statement; and (iii) to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement; provided, however, that (i) and (ii) do not apply if the information required to be included in a post-effective amendment thereby is contained in periodic reports filed by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference into the Registration Statement.
(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(4) That, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act that is incorporated by reference in this Registration Statement shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the provisions described under Item 6 above, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, California, on this 1st day of June, 2016.
ADAMIS PHARMACEUTICALS CORPORATION
By:
/s/ Robert O. Hopkins
Robert O. Hopkins
Chief Financial Officer
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS that each individual whose signature appears below constitutes and appoints Dennis J. Carlo and Robert O. Hopkins, and each of them, his attorneys-in-fact, and agents, each with the power of substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney may be signed in one or more counterparts.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Name
Title
Date
Principal Executive Officer:
/s/ Dennis J. Carlo
Chief Executive Officer and Director
June 1, 2016
Dennis J. Carlo, Ph.D.
Principal Financial Officer
and Principal Accounting Officer:
/s/ Robert O. Hopkins
Vice President, Finance, Chief Financial Officer
June 1, 2016
Robert O. Hopkins
and Secretary
Directors:
/s/ David J. Marguglio
Director
June 1, 2016
David J. Marguglio
/s/ William C. Denby, III
Director
June 1, 2016
William C. Denby, III
/s/ Robert B. Rothermel
Director
June 1, 2016
Robert B. Rothermel
/s/ Richard C. Williams
Director
June 1, 2016
Richard C. Williams